Winslow Capital Management LLC Has $564.03 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Winslow Capital Management LLC lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 17.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,080,601 shares of the medical equipment provider’s stock after selling 232,184 shares during the period. Intuitive Surgical comprises approximately 2.0% of Winslow Capital Management LLC’s portfolio, making the stock its 14th biggest position. Winslow Capital Management LLC owned about 0.30% of Intuitive Surgical worth $564,030,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of ISRG. Norges Bank purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $2,401,493,000. Proficio Capital Partners LLC lifted its position in Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after buying an additional 948,902 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at $313,769,000. Wilmington Savings Fund Society FSB boosted its stake in shares of Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after buying an additional 552,058 shares during the period. Finally, Vanguard Group Inc. grew its holdings in shares of Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after acquiring an additional 360,591 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares of the company’s stock, valued at $2,793,033.06. The trade was a 60.72 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 in the last quarter. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $457.63 on Wednesday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The firm has a market capitalization of $163.00 billion, a P/E ratio of 71.39, a P/E/G ratio of 5.85 and a beta of 1.55. The company has a 50-day simple moving average of $538.35 and a 200-day simple moving average of $532.09.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of research reports. Raymond James lifted their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Evercore ISI boosted their price target on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. JPMorgan Chase & Co. lifted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. UBS Group boosted their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Finally, Leerink Partners lifted their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.